Page 143 - 南京医科大学学报自然科学版
P. 143
第43卷第10期 东 瑞,黄丽丽,王 洁. 戊型肝炎重症化与慢性化免疫学机制研究进展[J].
2023年10月 南京医科大学学报(自然科学版),2023,43(10):1464-1469 ·1469 ·
发病机制[J]. 临床肝胆病杂志,2022,38(7):1629- chemotactic factors in LPS⁃stimulated human PMA⁃THP1
1633 cells by inhibiting NF⁃ κB pathway[J]. Viral Immunol,
[28] MAJUMDAR M,RATHO R K,CHAWLA Y,et al. Role 2016,29(2):105-111
of TLR gene expression and cytokine profiling in the im⁃ [40] RAFIEI A,AJAMI A,MOHAMMAD MIRABI A,et al. Se⁃
munopathogenesis of viral hepatitis E[J]. J Clin Virol, rum levels of soluble CD26,a novel prognostic marker for
2015,73:8-13 hepatitis E infection[J]. Jundishapur J Microbiol,2016,9
[29] SEHGAL R,PATRA S,DAVID P,et al. Impaired mono⁃ (2):1-6
cyte⁃macrophage functions and defective Toll⁃like recep⁃ [41] WU J,GUO Y,LU X,et al. Th1/Th2 cells and associated
tor signaling in hepatitis E virus⁃infected pregnant women cytokines in acute hepatitis e and related acute liver fai⁃
with acute liver failure[J]. Hepatology,2015,62(6): lure[J]. J Immunol Res,2020,2020:6027361
1683-1696 [42] RAMDASI A Y,ARYA R P,ARANKALLE V A. Effect
[30] JONES R M,NEISH A S. Gut microbiota in intestinal and of pregnancy on anti⁃HEV antibody titres,plasma cyto⁃
liver disease[J]. Annu Rev Pathol,2021,16:251-275 kines and the corresponding gene expression levels in the
[31] KOLODZIEJCZYK A A,FEDERICI S,ZMORA N,et al. PBMCs of patients presenting with self⁃recovering clini⁃
Acute liver failure is regulated by MYC⁃and microbiome⁃ cal and subclinical hepatitis E[J]. PLoS One,2014,9
dependent programs[J]. Nat Med,2020,26(12):1899- (8):e103257
1911 [43] 孙 蔚,朱海超,甘建和,等. 戊型病毒性肝炎患者外
[32] QIANG R,LI Y,DAI X,et al. NLRP3 inflammasome in 周血 Th17、Treg、Th17/Treg 变化及其临床意义[J]. 上
digestive diseases:from mechanism to therapy[J]. Front 海交通大学学报(医学版),2015,35(11):1647-1650,
Immunol,2022,13:978190 1660
[33] LI Y,YU P,KESSLER A L,et al. Hepatitis E virus infec⁃ [44] 习 林,游绍丽,刘鸿凌,等. 戊型肝炎肝衰竭患者的血
tion activates NOD⁃like receptor family pyrin domain⁃con⁃ 生化指标及血清IL⁃22表达水平研究[J]. 传染病信息,
taining 3 inflammasome antagonizing interferon response 2017,30(3):176-178
but therapeutically targetable[J]. Hepatology,2022,75 [45] LIN S,ZHANG Y J. Advances in hepatitis E virus biology
(1):196-212 and pathogenesis[J]. Viruses,2021,13(2):267
[34] THAKUR V,RATHO R K,SINGH M P,et al. NLRP3 in⁃ [46] KEMMING J,GUNDLACH S,PANNING M,et al. Mecha⁃
+
flammasome activation is a prognostic marker of recovery nisms of CD8 T⁃cell failure in chronic hepatitis E virus
in HEV ⁃ infected patients[J]. Curr Microbiol,2022,79 infection[J]. J Hepatol,2022,77(4):978-990
(2):1-13 [47] NEUMANN ⁃ HAEFELIN C. Paving the way for T cell ⁃
[35] HAN C Y,RHO H S,KIM A,et al. FXR inhibits endo⁃ based immunotherapies in chronic hepatitis E[J]. J Hep⁃
plasmic reticulum stress⁃induced NLRP3 inflammasome atol,2019,71(4):648-650
in hepatocytes and ameliorates liver injury[J]. Cell Rep, [48] SOON C F,BEHRENDT P,TODT D,et al. Defining virus⁃
+
2018,24(11):2985-2999 specific CD8 TCR repertoires for therapeutic regenera⁃
[36] ROOKS M G,GARRETT W S. Gut microbiota,metabo⁃ tion of T cells against chronic hepatitis E[J]. J Hepatol,
lites and host immunity[J]. Nat Rev Immunol,2016,16 2019,71(4):673-684
(6):341-352 [49] ZHAO L,YU G,HAN Q,et al. TIM⁃3:an emerging target
[37] 邓超超. 戊型肝炎病毒感染慢性化机制及临床诊治进 in the liver diseases[J]. Scand J Immunol,2020,91(4):
展[J]. 重庆医学,2018,47(7):966-968 e12825
[38] HE M,WANG M,HUANG Y,et al. The ORF3 protein of [50] SUNEETHA P V,PISCHKE S,SCHLAPHOFF V,et al.
genotype 1 hepatitis E virus suppresses TLR3 ⁃ induced Hepatitis E virus(HEV)⁃specific T⁃cell responses are as⁃
NF ⁃ κB signaling via TRADD and RIP1[J]. Sci Rep, sociated with control of HEV infection[J]. Hepatology,
2016,6:27597 2012,55(3):695-708
[39] LEI Q,LI L,CAI J,et al. ORF3 of Hepatitis E virus in⁃ [收稿日期] 2023-04-07
hibits the expression of proinflammatory cytokines and (责任编辑:蒋 莉)